Abstract:Aminoacyl-tRNA synthetases (aaRSs) are an attractive class of antibacterial drug targets due to their essential roles in protein translation. While most traditional aaRS inhibitors target the binding pockets of substrate amino acids and/or ATP, we recently developed a class of novel tRNA-amino acid dual-site inhibitors including inhibitor 3 ((2S,3R)-2-amino-N-((E)-4-(6,7-dichloro-4-oxoquinazolin-3(4H)-yl)but-2-en-1-yl)-3-hydroxybutanamide) against threonyl-tRNA synthetase (ThrRS). Here, the binding modes and structure-activity relationships (SARs) of these inhibitors were analyzed by the crystal structures of Salmonella enterica ThrRS (SeThrRS) in complex with three of them. Based on the cocrystal structures, twelve quinazolinone-threonine hybrids were designed and synthesized, and their affinities, enzymatic inhibitory activities, and cellular potencies were evaluated. The best derivative 8g achieved a Kd value of 0.40 μM, an IC50 value of 0.50 μM against SeThrRS and MIC values of 16∼32 μg/mL against the tested bacterial strains. The cocrystal structure of the SeThrRS-8g complex revealed that 8g induced a bended conformation for Met332 by forming hydrophobic interactions, which better mimicked the binding of tRNAThr to ThrRS. Moreover, the inhibitory potency of 8g was less impaired than a reported ATP competitive inhibitor at high concentrations of ATP, supporting our hypothesis that tRNA site inhibitors are likely superior to ATP site inhibitors in vivo, where ATP typically reaches millimolar concentrations.

Tyrosyl-Trna Synthetase Inhibitors As Antibacterial Agents: Synthesis, Molecular Docking and Structure-Activity Relationship Analysis of 3-Aryl-4-arylaminofuran-2(5h)-ones

4-Alkoxy-3-arylfuran-2(5h)-ones As Inhibitors of Tyrosyl-Trna Synthetase: Synthesis, Molecular Docking and Antibacterial Evaluation.

3-Aryl-4-acyloxyethoxyfuran-2(5H)-ones as inhibitors of tyrosyl-tRNA synthetase: synthesis, molecular docking and antibacterial evaluation.

4-Hydroxy-3-(naphthalen-1-ylmethyl)thiophen-2(5h)-one As Inhibitors of Tyrosyl-Trna Synthase: Synthesis, Molecular Docking and Antibacterial Evaluation

Synthesis and Evaluation of New Tyrosyl-Trna Synthetase Inhibitors As Antibacterial Agents Based on a N2-(arylacetyl)glycinanilide Scaffold

Synthesis, structure, molecular docking, and structure-activity relationship analysis of enamines: 3-aryl-4-alkylaminofuran-2(5H)-ones as potential antibacterials.

Novel Aminopyrimidinyl Benzimidazoles As Potentially Antimicrobial Agents: Design, Synthesis and Biological Evaluation

Design, synthesis, and biological evaluation of novel carbazole aminothiazoles as potential DNA-targeting antimicrobial agents

Adenosine Analogs As Inhibitors of Tyrosyl-Trna Synthetase: Design, Synthesis and Antibacterial Evaluation.

Synthesis and Evaluation of Adenosine Containing 3-Arylfuran-2(5h)-ones As Tyrosyl-Trna Synthetase Inhibitors

Synthesis, structure and structure-activity relationship analysis of 3-tert-butoxycarbonyl-2-arylthiazolidine-4-carboxylic acid derivatives as potential antibacterial agents.

Design, Synthesis and Molecular Docking of Salicylic Acid Derivatives Containing Metronidazole As a New Class of Antimicrobial Agents

Novel 3-arylfuran-2(5H)-one-fluoroquinolone hybrid: design, synthesis and evaluation as antibacterial agent.

Metronidazole Containing Pyrazole Derivatives Potently Inhibit Tyrosyl-Trna Synthetase: Design, Synthesis, and Biological Evaluation

Synthesis and Antibacterial Activity of Novel Triazolo[4,3-a]pyrazine Derivatives

Synthesis, molecular docking and biological evaluation of 3-arylfuran-2(5H)-ones as anti-gastric ulcer agent

Structure-guided optimization and mechanistic study of a class of quinazolinone-threonine hybrids as antibacterial ThrRS inhibitors

Novel 1,3,4-Oxadiazole Thioether Derivatives Targeting Thymidylate Synthase As Dual Anticancer/antimicrobial Agents.

Towards new bioactive fluorine-containing 1,3,4-oxadiazole-amide derivatives: synthesis, antibacterial activity, molecular docking and molecular dynamics simulation study

Synthesis, Characterization, and Biological Evaluation of Novel 7-Oxo-7H-thiazolo[3,2-b]-1,2,4-triazine-2-carboxylic Acid Derivatives

Synthesis, Structure, and Antibacterial Activity of Novel 5-Arylpyrazole Derivatives